CH and SCH are associated with some metabolic disorders including insulin resistance or high insulin levels, dyslipidemia, obesity, and endothelial dysfunction [22–24], which are closely associated with atherosclerosis and cardiovascular risk. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.